Skip to main content
Clinical Trials/CTRI/2022/09/045705
CTRI/2022/09/045705RecruitingPhase 4

Non-opioid versus Opioid Perioperative Analgesia In Neurosurgery: A prospective Multi-centric Randomized Controlled Trial (NO PAIN Trial)

Sriganesh Kamath5 sites in 1 country500 target enrollmentStarted: September 20, 2022Last updated:

Trial Snapshot

Phase
Phase 4
Status
Recruiting
Sponsor
Enrollment
500
Locations
5
Primary Endpoint
1.Rescue fentanyl consumption during surgery

Study Overview

Brief Summary

Opioids are associated with unwanted adverse effects. Prolonged, overuse of opioid is a major public health problem across the world. In the healthcare setting, maximal opioid usage occurs during surgery and pain management. To overcome opioid-associated complications, alternatives to opioids are explored. Dexmedetomidine when added to opioid reduces the adverse effects and anesthetic and opioid consumption in neurosurgical patients. Our pilot study showed non-inferiority of dexmedetomidine (as primary non-opioid analgesic) to fentanyl (opioid analgesic) for perioperative pain management in neurosurgery. Hence, we intend to conduct this larger trial to confirm our preliminary findings. This will provide an effective and safe alternative to opioids for perioperative pain management.

Study Design

Study Type
Interventional
Allocation
Computer generated randomization
Masking
Participant, Investigator, Outcome Assessor and Date-entry Operator Blinded

Eligibility Criteria

Ages
18.00 Year(s) to 65.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • •All consecutive consenting adult patients undergoing elective craniotomies for supratentorial brain tumors with Glasgow Coma Scale score of 15 will be included in this trial.

Exclusion Criteria

  • •We will exclude patients from this trial if they do not consent or if they have a current or past history of ischemic heart disease, cardiac failure (New York Heart Association grade ≥ 3), heart block or arrhythmia, untreated hypertension and diabetes mellitus, emergency surgery, pre-existing pain and receiving regular long-term drugs to manage pain, history of vomiting, previous cranial surgery, allergy to study drugs and opioid dependence as per the Diagnostic and Statistical Manual of mental disorders IV criteria.

Outcomes

Primary Outcomes

1.Rescue fentanyl consumption during surgery

Time Frame: 1.During surgery | 2.After surgery

2.Postoperative pain using Numerical Rating Scale score

Time Frame: 1.During surgery | 2.After surgery

Secondary Outcomes

  • Patient satisfaction(24 hours after surgery)
  • Persistent pain and quality of life(At 3 and 6 months after surgery)
  • Adverse events(During and upto 60 minutes after surgery)
  • Quality of sleep(1st postoperative day)
  • Quality of recovery from anesthesia and emergence delirium(End of anesthesia till 60 minutes after surgery)

Investigators

Sponsor
Sriganesh Kamath
Sponsor Class
Other [self]

Study Sites (5)

Loading locations...

Similar Trials